Codexis, Inc. balance sheet
At the end of fiscal 2025, Codexis, Inc. had total assets of $148m, total liabilities of $97.3m and shareholders' equity of $50.5m. It held $50.8m in cash against $42.2m of debt: net cash of $8.6m.
Balance sheet
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 32 | 72 | 26 | 32 | 22 | 26 | 23 | 19 | 31 | 53 | 90 | 149 | 117 | 114 | 65 | 19 | 51 | 27 |
| Receivables | — | 15 | 19 | 8 | 5 | 4 | 7 | 6 | 11 | 12 | 9 | 14 | 25 | 32 | 10 | 19 | 11 | 12 |
| Inventory | — | 3 | 4 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 2 | 3 | 2 | 2 | 2 |
| Total current assets | — | 92 | 79 | 60 | 36 | 33 | 33 | 27 | 45 | 68 | 114 | 184 | 162 | 163 | 93 | 99 | 97 | 72 |
| Goodwill | — | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 |
| Total assets | — | 141 | 136 | 100 | 59 | 48 | 45 | 36 | 54 | 79 | 149 | 222 | 246 | 250 | 137 | 149 | 148 | 120 |
| Accounts payable | — | 9 | 10 | 4 | 4 | 5 | 3 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 6 | 3 | 2 | 3 |
| Deferred revenue (current) | — | 5 | 4 | 2 | 2 | 3 | 6 | 2 | 12 | 5 | 0 | 2 | 3 | 5 | 10 | 0 | 7 | 1 |
| Total current liabilities | — | 27 | 28 | 16 | 11 | 14 | 15 | 12 | 25 | 18 | 15 | 25 | 33 | 49 | 36 | 24 | 25 | 24 |
| Short-term debt | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0 | 7 |
| Long-term debt | — | — | — | — | — | — | — | 0 | 0 | — | — | — | — | — | 0 | 29 | 40 | 34 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32 | 42 | 42 |
| Total liabilities | — | — | — | — | 17 | — | 22 | 17 | 29 | 23 | 44 | 52 | 82 | 106 | 50 | 82 | 97 | 87 |
| Shareholders' equity | −145 | 107 | 103 | 78 | 41 | 26 | 23 | 19 | 25 | 56 | 106 | 170 | 164 | 145 | 87 | 67 | 51 | 33 |
| Net debt (negative = net cash) | −32 | −72 | −26 | −32 | −22 | −26 | −23 | −19 | −31 | −53 | −90 | −149 | −117 | −114 | −65 | 13 | −9 | 15 |
| Shares outstanding | — | — | 36m | 38m | 38m | 40m | 40m | 41m | 48m | 54m | 59m | 64m | 65m | 66m | 70m | 82m | 90m | 91m |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 17 | 19 | 12 | 16 | 10 | 11 | 8 | 12 |
| Inventory | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Total current assets | 113 | 99 | 78 | 89 | 76 | 97 | 80 | 72 |
| Goodwill | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Total assets | 148 | 149 | 129 | 138 | 124 | 148 | 129 | 120 |
| Accounts payable | 4 | 3 | 6 | 1 | 2 | 2 | 2 | 3 |
| Deferred revenue (current) | 10 | 0 | 0 | 0 | 0 | 7 | 1 | 1 |
| Total current liabilities | 35 | 24 | 21 | 15 | 18 | 25 | 15 | 24 |
| Short-term debt | — | — | — | — | — | 0 | — | 7 |
| Long-term debt | 29 | 29 | 29 | 39 | 40 | 40 | 40 | 34 |
| Total debt | 29 | 29 | 29 | 39 | 40 | 40 | 40 | 41 |
| Total liabilities | 75 | 82 | 79 | 83 | 85 | 97 | 86 | 87 |
| Shareholders' equity | 73 | 67 | 50 | 56 | 39 | 51 | 43 | 33 |
| Shares outstanding | 81m | 82m | 83m | 90m | 90m | 90m | 91m | 91m |
Compare with peers
- Burning Rock Biotech Ltd balance sheet
- Exagen Inc. balance sheet
- Personalis, Inc. balance sheet
- Harvard Bioscience Inc balance sheet
- 908 Devices Inc. balance sheet
Head to head: BNR vs CDXSCDXS vs XGNCDXS vs PSNLCDXS vs HBIO
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies